| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2007-05-22 20:54:05 UTC |
|---|
| Update Date | 2020-11-09 23:17:54 UTC |
|---|
| HMDB ID | HMDB0006275 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Dopamine 3-O-sulfate |
|---|
| Description | Dopamine 3-O-sulfate is a sulfonated form of dopamine. In human blood circulation endogenous dopamine exists predominantly in the sulfated form and dopamine sulfate accounts for more than 90% of all dopamine. Dopamine-3-O-sulfate predominates in human plasma, with concentrations about 10-fold higher than those of the regioisomer dopamine-4-O-sulfate. Sulfonation is the most important metabolic pathway that interferes with the binding of dopamine to its receptors. The origins of this preponderance for Dopamine-3-O-sulfate have not been determined, although there has been speculation about the contribution of the specificity of transport proteins and/or arylsulfatases. It has also been proposed to depend on the regiospecificity of the metabolizing enzyme(s) for the 3-hydroxy group of dopamine. It is believed that the vast majority of circulating dopamine sulfate originates in the upper gastrointestinal tract, and indeed that is the main site of expression of the enzyme responsible for its formation. Aryl sulfotransferase (SULT1A3, EC 2.8.2.1) is an enzyme that catalyzes the sulfonation of many endogenous and exogenous phenols and catechols; the most important endogenous substrate is dopamine. SULT1A3 strongly favors the 3-hydroxy group of dopamine over the 4-hydroxy group and may indeed be primarily responsible for the difference between the circulating levels of dopamine sulfates in human blood. (PMID: 17548063 ). |
|---|
| Structure | NCCC1=CC(OS(O)(=O)=O)=C(O)C=C1 InChI=1S/C8H11NO5S/c9-4-3-6-1-2-7(10)8(5-6)14-15(11,12)13/h1-2,5,10H,3-4,9H2,(H,11,12,13) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-(2-Aminoethyl)-1,2-benzenediol 2-(hydrogen sulfate) | ChEBI | | [5-(2-Aminoethyl)-2-hydroxyphenyl]oxidanesulfonic acid | ChEBI | | Dopamine 3-monosulfate | ChEBI | | Dopamine 3-sulfate | ChEBI | | 4-(2-Aminoethyl)-1,2-benzenediol 2-(hydrogen sulfuric acid) | Generator | | 4-(2-Aminoethyl)-1,2-benzenediol 2-(hydrogen sulphate) | Generator | | 4-(2-Aminoethyl)-1,2-benzenediol 2-(hydrogen sulphuric acid) | Generator | | [5-(2-Aminoethyl)-2-hydroxyphenyl]oxidanesulfonate | Generator | | [5-(2-Aminoethyl)-2-hydroxyphenyl]oxidanesulphonate | Generator | | [5-(2-Aminoethyl)-2-hydroxyphenyl]oxidanesulphonic acid | Generator | | Dopamine 3-monosulfuric acid | Generator | | Dopamine 3-monosulphate | Generator | | Dopamine 3-monosulphuric acid | Generator | | Dopamine 3-sulfuric acid | Generator | | Dopamine 3-sulphate | Generator | | Dopamine 3-sulphuric acid | Generator | | Dopamine 3-O-sulfuric acid | Generator | | Dopamine 3-O-sulphate | Generator | | Dopamine 3-O-sulphuric acid | Generator |
|
|---|
| Chemical Formula | C8H11NO5S |
|---|
| Average Molecular Weight | 233.242 |
|---|
| Monoisotopic Molecular Weight | 233.035793157 |
|---|
| IUPAC Name | [5-(2-aminoethyl)-2-hydroxyphenyl]oxidanesulfonic acid |
|---|
| Traditional Name | dopamine 3-O-sulfate |
|---|
| CAS Registry Number | 51317-41-0 |
|---|
| SMILES | NCCC1=CC(OS(O)(=O)=O)=C(O)C=C1 |
|---|
| InChI Identifier | InChI=1S/C8H11NO5S/c9-4-3-6-1-2-7(10)8(5-6)14-15(11,12)13/h1-2,5,10H,3-4,9H2,(H,11,12,13) |
|---|
| InChI Key | NZKRYJGNYPYXJZ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Organic sulfuric acids and derivatives |
|---|
| Sub Class | Arylsulfates |
|---|
| Direct Parent | Phenylsulfates |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylsulfate
- Phenethylamine
- Phenoxy compound
- 2-arylethylamine
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Aralkylamine
- Monocyclic benzene moiety
- Sulfuric acid monoester
- Sulfate-ester
- Sulfuric acid ester
- Benzenoid
- Primary amine
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organooxygen compound
- Amine
- Primary aliphatic amine
- Organonitrogen compound
- Organic oxide
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 268 - 270 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.51 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.6884 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.39 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 218.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 508.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 273.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 87.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 168.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 52.7 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 263.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 290.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 741.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 653.4 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 144.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 867.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 169.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 191.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 514.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 393.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 272.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Dopamine 3-O-sulfate,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O | 2140.9 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,1TMS,isomer #2 | C[Si](C)(C)OS(=O)(=O)OC1=CC(CCN)=CC=C1O | 2084.2 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,1TMS,isomer #3 | C[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O)=C1 | 2240.6 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O[Si](C)(C)C | 2134.2 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O[Si](C)(C)C | 2260.7 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O[Si](C)(C)C | 3084.9 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #2 | C[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C)C(OS(=O)(=O)O)=C1 | 2233.1 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #2 | C[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C)C(OS(=O)(=O)O)=C1 | 2390.2 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #2 | C[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C)C(OS(=O)(=O)O)=C1 | 2963.4 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #3 | C[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O[Si](C)(C)C)=C1 | 2194.1 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #3 | C[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O[Si](C)(C)C)=C1 | 2340.5 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #3 | C[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O[Si](C)(C)C)=C1 | 3064.4 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #4 | C[Si](C)(C)N(CCC1=CC=C(O)C(OS(=O)(=O)O)=C1)[Si](C)(C)C | 2385.4 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #4 | C[Si](C)(C)N(CCC1=CC=C(O)C(OS(=O)(=O)O)=C1)[Si](C)(C)C | 2460.7 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TMS,isomer #4 | C[Si](C)(C)N(CCC1=CC=C(O)C(OS(=O)(=O)O)=C1)[Si](C)(C)C | 3307.9 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #1 | C[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C)C(OS(=O)(=O)O[Si](C)(C)C)=C1 | 2219.3 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #1 | C[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C)C(OS(=O)(=O)O[Si](C)(C)C)=C1 | 2440.0 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #1 | C[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C)C(OS(=O)(=O)O[Si](C)(C)C)=C1 | 2754.5 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C)[Si](C)(C)C)C=C1OS(=O)(=O)O | 2387.4 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C)[Si](C)(C)C)C=C1OS(=O)(=O)O | 2566.9 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C)[Si](C)(C)C)C=C1OS(=O)(=O)O | 2839.7 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #3 | C[Si](C)(C)OS(=O)(=O)OC1=CC(CCN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O | 2353.2 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #3 | C[Si](C)(C)OS(=O)(=O)OC1=CC(CCN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O | 2579.0 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TMS,isomer #3 | C[Si](C)(C)OS(=O)(=O)OC1=CC(CCN([Si](C)(C)C)[Si](C)(C)C)=CC=C1O | 2946.1 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,4TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C)[Si](C)(C)C)C=C1OS(=O)(=O)O[Si](C)(C)C | 2411.2 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,4TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C)[Si](C)(C)C)C=C1OS(=O)(=O)O[Si](C)(C)C | 2634.8 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,4TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C)[Si](C)(C)C)C=C1OS(=O)(=O)O[Si](C)(C)C | 2696.9 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O | 2379.4 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OS(=O)(=O)OC1=CC(CCN)=CC=C1O | 2325.0 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O)=C1 | 2497.3 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O[Si](C)(C)C(C)(C)C | 2604.1 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O[Si](C)(C)C(C)(C)C | 2793.2 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN)C=C1OS(=O)(=O)O[Si](C)(C)C(C)(C)C | 3120.6 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(OS(=O)(=O)O)=C1 | 2746.9 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(OS(=O)(=O)O)=C1 | 2874.2 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(OS(=O)(=O)O)=C1 | 3075.4 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2704.1 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2861.7 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O)C(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)=C1 | 3110.8 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(CCC1=CC=C(O)C(OS(=O)(=O)O)=C1)[Si](C)(C)C(C)(C)C | 2867.1 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(CCC1=CC=C(O)C(OS(=O)(=O)O)=C1)[Si](C)(C)C(C)(C)C | 2930.6 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(CCC1=CC=C(O)C(OS(=O)(=O)O)=C1)[Si](C)(C)C(C)(C)C | 3268.0 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2942.0 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)=C1 | 3208.6 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCC1=CC=C(O[Si](C)(C)C(C)(C)C)C(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2976.6 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1OS(=O)(=O)O | 3128.5 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1OS(=O)(=O)O | 3272.9 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1OS(=O)(=O)O | 3022.2 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OS(=O)(=O)OC1=CC(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O | 3072.4 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OS(=O)(=O)OC1=CC(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O | 3311.3 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OS(=O)(=O)OC1=CC(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=CC=C1O | 3083.3 | Standard polar | 33892256 | | Dopamine 3-O-sulfate,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1OS(=O)(=O)O[Si](C)(C)C(C)(C)C | 3328.2 | Semi standard non polar | 33892256 | | Dopamine 3-O-sulfate,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1OS(=O)(=O)O[Si](C)(C)C(C)(C)C | 3597.1 | Standard non polar | 33892256 | | Dopamine 3-O-sulfate,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(CCN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1OS(=O)(=O)O[Si](C)(C)C(C)(C)C | 2951.8 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Dopamine 3-O-sulfate GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9650000000-2db72db7d63697e55bd1 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dopamine 3-O-sulfate GC-MS (1 TMS) - 70eV, Positive | splash10-0fl0-9320000000-ace4fcc9cdb2373f726c | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Dopamine 3-O-sulfate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 10V, Positive-QTOF | splash10-0159-0090000000-b2228f1210694d4037be | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 20V, Positive-QTOF | splash10-014r-1950000000-c9ce0c682709c1c90e1d | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 40V, Positive-QTOF | splash10-0gdi-9300000000-f413b35bca5b45692bb0 | 2016-06-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 10V, Negative-QTOF | splash10-001i-0090000000-c18c16811fdd8fb7e8d7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 20V, Negative-QTOF | splash10-0udi-1930000000-37551dd11cac8f51977a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 40V, Negative-QTOF | splash10-0f8i-5900000000-6729c4999d2afb12eec0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 10V, Negative-QTOF | splash10-001i-0090000000-b5c60a607f4b8ffe8309 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 20V, Negative-QTOF | splash10-001j-5090000000-6dc0ebdf64e66d55361a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 40V, Negative-QTOF | splash10-01ow-9100000000-c48fe767b4f0b00bc40e | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 10V, Positive-QTOF | splash10-000i-0920000000-5bc862fdad49e730b60a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 20V, Positive-QTOF | splash10-000i-0900000000-751f9057ce9f08d81036 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dopamine 3-O-sulfate 40V, Positive-QTOF | splash10-066u-5900000000-9d59879b17c28b88d464 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|